Display options
Share it on

World J Exp Med. 2012 Oct 20;2(5):86-91. doi: 10.5493/wjem.v2.i5.86. eCollection 2012 Oct 20.

Breast cancer and protein biomarkers.

World journal of experimental medicine

Lay-Harn Gam

Affiliations

  1. Lay-Harn Gam, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia.

PMID: 24520539 PMCID: PMC3905586 DOI: 10.5493/wjem.v2.i5.86

Abstract

Breast cancer is a healthcare concern of women worldwide. Despite procedures being available for diagnosis, prognosis and treatment of breast cancer, researchers are working intensively on the disease in order to improve the life quality of breast cancer patients. At present, there is no single treatment known to bring a definite cure for breast cancer. One of the possible solutions for combating breast cancer is through identification of reliable protein biomarkers that can be effectively used for early detection, prognosis and treatments of the cancer. Therefore, the task of identification of biomarkers for breast cancer has become the focus of many researchers worldwide.

Keywords: Biomarkers; Breast cancer; Protein; Proteomics

References

  1. Curr Pharmacogenomics Person Med. 2009 Dec 1;7(4):263-274 - PubMed
  2. Cell. 2011 Mar 4;144(5):646-74 - PubMed
  3. Int J Cancer. 1999 Aug 27;82(5):721-6 - PubMed
  4. Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):5978-86 - PubMed
  5. Cancer Genet Cytogenet. 2004 Dec;155(2):108-18 - PubMed
  6. J Clin Oncol. 2001 Jan 1;19(1):44-53 - PubMed
  7. J Proteome Res. 2012 Feb 3;11(2):1078-88 - PubMed
  8. Clin Cancer Res. 2010 Jan 15;16(2):681-90 - PubMed
  9. Mol Biotechnol. 2005 Mar;29(3):233-44 - PubMed
  10. Cancer Res. 2001 Jan 1;61(1):76-80 - PubMed
  11. Biochim Biophys Acta. 2007 Jun;1770(6):847-56 - PubMed
  12. Genomics Proteomics Bioinformatics. 2006 Aug;4(3):165-72 - PubMed
  13. Science. 1987 Jan 9;235(4785):177-82 - PubMed
  14. Breast Cancer (Auckl). 2009 Aug 17;3:47-60 - PubMed
  15. Mol Biotechnol. 2002 Oct;22(2):139-52 - PubMed
  16. J Proteomics. 2012 May 17;75(9):2745-52 - PubMed
  17. Nat Immunol. 2008 Apr;9(4):405-14 - PubMed
  18. Proteomics. 2010 Oct;10(19):3525-32 - PubMed
  19. Maturitas. 2001 Feb 28;38(1):103-13; discussion 113-6 - PubMed
  20. Biomark Insights. 2007 Feb 07;1:1-48 - PubMed
  21. Histol Histopathol. 2011 Jun;26(6):761-8 - PubMed
  22. Ginekol Pol. 2003 Sep;74(9):754-60 - PubMed
  23. Dis Markers. 2010;28(3):149-65 - PubMed
  24. Exp Cell Res. 2010 Dec 10;316(20):3522-31 - PubMed
  25. J Clin Oncol. 2002 Feb 1;20(3):719-26 - PubMed
  26. Cancer Res. 2002 Nov 15;62(22):6740-9 - PubMed
  27. Mol Cell Proteomics. 2007 Jan;6(1):43-55 - PubMed
  28. Am Rev Respir Dis. 1991 Sep;144(3 Pt 2):S42-7 - PubMed
  29. J Insur Med. 2007;39(4):251-8 - PubMed
  30. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8368-73 - PubMed
  31. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Feb 5;815(1-2):215-25 - PubMed
  32. Clin Chem. 2002 Aug;48(8):1147-50 - PubMed
  33. J Clin Oncol. 2009 Mar 10;27(8):1323-33 - PubMed
  34. Clin Chem. 2001 Apr;47(4):624-30 - PubMed
  35. Dis Markers. 2010;29(5):231-42 - PubMed
  36. Int J Biol Markers. 1998 Oct-Dec;13(4):179-87 - PubMed
  37. Clin Chem. 2002 Aug;48(8):1160-9 - PubMed
  38. J Pathol. 2006 Jun;209(2):147-56 - PubMed
  39. J Proteomics. 2012 Feb 2;75(4):1276-83 - PubMed
  40. J Natl Cancer Inst Monogr. 2001;(30):17-21 - PubMed
  41. Lancet Oncol. 2001 Nov;2(11):698-704 - PubMed
  42. J Clin Oncol. 2003 May 15;21(10 Suppl):200s-205s - PubMed
  43. Expert Opin Investig Drugs. 2010 Apr;19 Suppl 1:S79-89 - PubMed

Publication Types